These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 12555338

  • 1. [Evaluation of the efficacy and tolerance of naftidrofuryl in patients presenting with exertional angina. Multicenter double-blind versus placebo study].
    Hirsch JL, Bensoussan JJ, Mosnier M, Lehert P.
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):137-45. PubMed ID: 12555338
    [Abstract] [Full Text] [Related]

  • 2. [Value of the combination of trimetazidine (Vastarel 20 mg) with diltiazem (Tildiem 60 mg) in stable effort angina. A double-blind versus placebo multicenter study].
    Lévy S.
    Ann Cardiol Angeiol (Paris); 1995 Apr; 44(4):203-12. PubMed ID: 7632029
    [Abstract] [Full Text] [Related]

  • 3. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
    Heller GV, Sridharan M, Morse J, Glasser S, Beach CL.
    Pharmacotherapy; 1997 Apr; 17(4):760-6. PubMed ID: 9250554
    [Abstract] [Full Text] [Related]

  • 4. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E, Bahnini A, Mouren X, Gamand S.
    Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
    [Abstract] [Full Text] [Related]

  • 5. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand.
    Szwed H, Sadowski Z, Elikowski W, Koronkiewicz A, Mamcarz A, Orszulak W, Skibińska E, Szymczak K, Swiatek J, Winter M.
    Eur Heart J; 2001 Dec; 22(24):2267-74. PubMed ID: 11728147
    [Abstract] [Full Text] [Related]

  • 6. Treatment of stage II chronic arterial disease of the lower limbs with the serotonergic antagonist naftidrofuryl: results after 6 months of a controlled, multicenter study.
    Adhoute G, Andreassian B, Boccalon H, Cloarec M, Di Maria G, Lefebvre O, Mondine P, Plagnol P, Pointel JP, Quancard X.
    J Cardiovasc Pharmacol; 1990 Dec; 16 Suppl 3():S75-80. PubMed ID: 1369725
    [Abstract] [Full Text] [Related]

  • 7. Anti-ischaemic efficacy and tolerability of trimetazidine administered to patients with angina pectoris: results of three studies.
    Szwed H, Hradec J, Préda I.
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S25-8. PubMed ID: 11286304
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of naftidrofuryl in patients with vascular or mixed dementia: results of a multicenter, double-blind trial.
    Emeriau JP, Lehert P, Mosnier M.
    Clin Ther; 2000 Jul; 22(7):834-44. PubMed ID: 10945510
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study.
    Ruzyllo W, Szwed H, Sadowski Z, Elikowski W, Grzelak-Szafranska H, Orszulak W, Szymczak K, Winter M.
    Curr Med Res Opin; 2004 Sep; 20(9):1447-54. PubMed ID: 15383193
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of anti-ischemic effect of bepridil and diltiazem evaluated by exercise test in patients with coronary disease. A multicenter study. Groupe d'Investigateurs].
    Sellier P, Quilliet L.
    Ann Cardiol Angeiol (Paris); 1997 Nov; 46(9):602-8. PubMed ID: 9538375
    [Abstract] [Full Text] [Related]

  • 11. Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS).
    Forslund L, Hjemdahl P, Held C, Björkander I, Eriksson SV, Brodin U, Rehnqvist N.
    Eur Heart J; 2000 Jun; 21(11):901-10. PubMed ID: 10806014
    [Abstract] [Full Text] [Related]

  • 12. [Anti-angina effect of amiodarone in therapy-resistant angina pectoris].
    Meyer BJ, Gschwend S, Marx B, Amann FW.
    Schweiz Med Wochenschr; 1992 Jan 18; 122(3):70-2. PubMed ID: 1346342
    [Abstract] [Full Text] [Related]

  • 13. [Consequences of obliterating arteriopathy of the legs on the professional activity of patients and external assistance].
    Rolland N, Lebrun T, Comte S, Sailly JC.
    J Mal Vasc; 1999 Jun 18; 24(3):208-13. PubMed ID: 10467531
    [Abstract] [Full Text] [Related]

  • 14. Naftidrofuryl in quality of life (NIQOL). A Belgian study.
    D'Hooge D, Lehert P, Clement DL.
    Int Angiol; 2001 Dec 18; 20(4):288-94. PubMed ID: 11782694
    [Abstract] [Full Text] [Related]

  • 15. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy.
    Klein W, Mitrovic V, Neuss H, Schlepper M, Cocco G, Prager G, Fitscha P, Meisner W.
    J Cardiovasc Pharmacol; 1991 Dec 18; 17 Suppl 1():S50-2. PubMed ID: 16296710
    [Abstract] [Full Text] [Related]

  • 16. [Comparison of the antispastic effect of Bi-Tildiem 120 mg and Tildiem 60mg].
    Yvorra S, Desfossez L, Panagides D, De La Garoullaye A, Bory M.
    Ann Cardiol Angeiol (Paris); 1995 Sep 18; 44(7):372-7. PubMed ID: 8561443
    [Abstract] [Full Text] [Related]

  • 17. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K, Bestehorn HP, Roskamm H.
    J Cardiovasc Pharmacol; 1990 Sep 18; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [Abstract] [Full Text] [Related]

  • 18. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
    Rousseau MF, Pouleur H, Cocco G, Wolff AA.
    Am J Cardiol; 2005 Feb 01; 95(3):311-6. PubMed ID: 15670536
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.